Weekly Digest – Jan 2024 Weekly Digest – Jan 2024 17 Jan 2024: Orion invests $415.6M in LegoChem Biosciences to lead in next-gen anticancer drugs with ADC technology Orion invests $415.6 million to acquire a 25% stake in biotech firm […]
Weekly Digest – Jan 2024 Weekly Digest – Jan 2024 16 Jan 2024: Johnson & Johnson acquires ambrx for $2 Billion to boost next-gen cancer therapies Johnson & Johnson is acquiring Ambrx Biopharma for $2 billion in an all-cash merger […]
Weekly Digest – Jan 2024 Weekly Digest – Jan 2024 16 Jan 2024: LegoChem secures $411M funding from confectionery firm in ADC advancement LegoChem Bioscience, fueled by a $411 million investment from Orion, is expanding its R&D efforts in the […]
Weekly Digest – Jan 2024 Weekly Digest – Jan 2024 08 Jan 2024: At JPM24, Novartis CEO discusses resisting the ADC field trend among cancer players Novartis CEO reveals the company’s strategic choice of radioligand therapies over antibody-drug conjugates (ADCs) […]
